Coral Reefs

, Volume 26, Issue 1, pp 7–13 | Cite as

Phage therapy of coral disease

  • R. Efrony
  • Y. Loya
  • E. Bacharach
  • E. RosenbergEmail author
Open Access


At present there are no known procedures for preventing or treating infectious diseases of corals. Toward this end, the use of phage therapy has been investigated. Lytic bacteriophages (phages) were isolated for two bacterial pathogens that are responsible for coral diseases, Vibrio coralliilyticus, which is the causative agent of bleaching and tissue lysis of Pocillopora damicornis, and Thalosomonas loyaeana, which causes the white plague-like disease of Favia favus. By using these phages in controlled aquaria experiments, it was demonstrated that each of these diseases could be controlled by the pathogen-specific phage. The data indicate that initially the phages bind to the pathogen in seawater and are then brought to the coral surface where they multiply and lyse the pathogen. The phages remained associated with the coral and could prevent subsequent infections. These data suggest that phage therapy has the potential to control the spread of infectious coral diseases.


Phage therapy Bacteriophage Coral disease Pocillopora damicornis Favia favus 


Infectious diseases of corals cause serious damage to coral reefs throughout the world (Green and Bruckner 2000; Harvell et al. 2002). In several cases, the microorganism responsible for the disease has been identified (Kushmaro et al. 1996; Richardson 1998; Ritchie et al. 2001; Rosenberg and Ben-Haim 2002). It is now clear that environmental factors, especially increased seawater temperature and pollution, contribute to disease formation (Rosenberg and Ben-Haim 2002; Bruno et al. 2003; Kerri et al. 2004; Kuntz et al. 2005; Kline et al. 2006), and every effort should be made to avoid these deleterious factors. However, it is equally important to develop therapeutic methods for preventing and curing infectious diseases of corals. Two widely used methods for controlling human diseases, immunization and antibiotic treatment, are not applicable to coral diseases because corals have no adaptive immune system (Nair et al. 2005) and introduction of antibiotics in an open system like a coral reef is not practical. An alternative therapeutic method is phage therapy.

The use of bacterial viruses (bacteriophages, or phages for short) for the treatment of human disease has had a long and rocky history (Lederberg 1996; Chanishvili et al. 2001; Sulakveldize et al. 2001). However, many of the intrinsic difficulties of treating humans by phage therapy are irrelevant to corals, such as uptake of the phages by the spleen, and destruction by opsonization and neutralizing antibodies. The major advantages of phage therapy of coral diseases are host specificity, self replication and environmental safety. The phage only attacks and destroys the specific pathogen, leaving the remaining beneficial microorganisms untouched. The phage multiplies rapidly at the expense of its host bacterium, increasing the phage titer for more effective control of the pathogen. When the pathogen concentration decreases sufficiently, the phage will also decline (Weld et al. 2004). Phage therapy has been used to protect fish against experimentally-induced bacterial infections in aquaculture (Nakai and Park 2002).

In this study, the application of phage therapy was tested with two coral diseases: tissue lysis of Pocillopora damicornis by Vibrio coralliilyticus (Ben-Haim and Rosenberg 2002; Ben-Haim et al. 2003a, b) and the white plague-like disease of Eilat (Gulf of Aqaba, Red Sea) corals caused by Thalosomonas loyaeana (Barash et al. 2005; Thompson et al. 2006). V. coralliilyticus is a novel species that has been recently isolated from diseased corals and other marine invertebrates in the Red Sea, Indian Ocean, Atlantic Ocean and Great Barrier Reef (Ben-Haim and Rosenberg 2002; Bourne and Munn 2005). At 25°C, V. coralliilyticus causes bleaching of P. damicornis in 20–25 days, whereas at 27–30°C the pathogen causes tissue lysis and death in 10–15 days (Ben-Haim et al. 2003 a, b). The white plague-like disease is currently the most serious disease on the Eilat coral reef. T. loyaeana, is the causative agent of this disease on several large corals, including Favia favus, Platygyra sp. and Goniastrea sp. Approximately 10% of the colonies of each of these genera show progressive signs of the disease or are dead as a result of the infection. In the field, the disease spreads within the colony at a maximum recorded rate of 11 mm per day (Barash et al. 2005).

Materials and methods

Bacteria, media and growth conditions

Strains were routinely cultivated in liquid MBT medium (1.8% Marine Broth, 0.9% NaCl and 0.5% Difco Tryptone) at 30°C. Liquid cultures were prepared in 125 ml flasks containing 10 ml MBT, inoculated with one colony, and incubated at 30°C with shaking (160 rpm) for 48 h. The strains were maintained on MB Agar (1.8% Marine Broth, 0.9% NaCl and 1.8% Bacto Agar). Stock cultures were stored in 15% glycerol at −70°C.

Bacteriophage isolation and preparation of high titer phage stocks

Seawater was collected from the Red Sea near the Intrauniversity station in Eilat, Israel. Aliquots of 500 ml were filtered through 0.22 μm membrane filters (Millipore). The filtrates were then concentrated 100-fold (TFF-Tangential Flow Filtration) and either plated directly or were used in enrichment cultures. Plaques were obtained over lawns of the different hosts: V. coralliilyticus or T. loyaeana by the soft agar overlay technique (Adams 1959), using 0.6% agar and incubating at 30°C for 24 h. Several rounds of plaque purifications were performed to ensure a pure phage stock. High titer stocks were made by infecting fresh culture of bacteria (A 600 = 0.6) with approximately 1 × 106 pfu ml−1. After about 2 h the culture became clear and was centrifuged to remove any remaining bacteria and large debris.

Electron microscopy

Phages were classified on the basis of morphology determined by electron microscopy. High titer bacteriophage lysates were negatively stained with 1% uranyl acetate and examined with a JEOL 840A electron microscope at 80 kV.

Collection and maintenance of corals

Corals for laboratory infection experiments were collected by SCUBA diving off Eilat in the Gulf of Aqaba, Red Sea, from depths of 2–6 m. In the case of P. damicornis, ca. 2 cm2 pieces were taken from the same colony. With F. favus, each piece was a separate small colony (ca. 3 cm diameter). The corals were then allowed to recover and regenerate in 3–10 l, glass-covered aerated aquaria at the same seawater temperature (21–26°C) at which they were collected. After tissue recovery the corals were slowly acclimated to the experimental temperature by increasing the temperature no more than 0.5°C per day. The corals were maintained at the experimental temperature for a further 7–14 days prior to the experiment. If any fragment failed to heal (completely cover over the broken edges with new tissue, and exhibit dark pigmentation), it was not used in the experiments. The corals were maintained in freshly prepared artificial seawater (ASW, Instant Ocean, USA) adjusted to salinity of 35–37 ppt. Water was replaced every 3–6 days. The aquaria were aerated and illuminated with fluorescent lamps (Sylvania, Aquastar 10,000 K) by using a regimen of 12 h light:12 h of darkness.

Phage adsorption experiments

Overnight cultures of V. corallilyticus and T. loyaeana were transferred to fresh MBT medium and allowed to grow until they reached A 600 = 0.4 (exponential phase). The cultures were then centrifuged, and the pellets washed and resuspended in either MBT medium or ASW. To prevent multiple adsorptions, the adsorption experiments were performed with final concentrations of 5 × 106 and 5 × 10ml−1 of bacteria and phages, respectively. Samples were withdrawn at timed intervals and diluted 100-fold to prevent further adsorption. The suspension was then centrifuged for 2 min at 8,000g to remove adsorbed phages, and the supernatant fluid (containing free virons) was assayed for phage by the soft agar overlay technique. One-step growth curves for each phage was performed as described in Adams (1959).

Phage therapy of the white-plague-like disease of F. favus

Healthy F. favus and corals showing signs of the white plague-like disease (ca. 3 cm diameter) were placed in separate aquaria and maintained as described above at 25°C. After 48 h, 300 ml of water from the aquarium with the diseased coral and 300 ml of artificial seawater were placed in each of nine aquaria. A single healthy coral was then placed in each aquarium. Six aquaria were inoculated with phage BA3 (three received 104 pfu ml−1 and three received 106 pfu ml−1). The other three aquaria served as no phage controls.

Protection of the coral P. damicornis against infection by V. coralliilyticus with phage YB2

Coral fragments were placed in 2.5 l aquaria containing 2 l of freshly prepared artificial seawater (4 or 5 corals per aquarium). All four aquaria were then infected with a 48 h culture of V. coralliilyticus at a final concentration of 105 bacteria per ml. Two aquaria containing a total of nine corals served as the no-phage controls. The other two aquaria containing a total of nine corals were inoculated with phage YB2 to reach 10ml−1. Seawater in the aquaria was replaced every 7 days by removing the corals, draining and rinsing the aquaria, and adding back the rinsed corals to fresh seawater.

Determination of phage genome size

Bacteriophage preparations (at least 10pfu ml−1) were treated with DNase I and RNase A at 37°C for 15 min to remove contaminating nucleic acids, then precipitated by 20% PEG (containing 2 M NaCl), lysed by addition of EDTA (final concentration 20 mM) and SDS (final concentration 0.5%), followed by incubation at 68°C for 5 min. The nucleic acids were purified using a phenol, phenol/chloroform, chloroform extraction, and precipitated with ethanol (Sambrook et al. 1989). The DNA of phage YB2 was fragmented by the EcoRI and PstI. The DNA of phage BA3 was fragmented by the following enzymes: BamHI, HindIII, EcoRV and EcoRI . All restriction enzymes used were products of Fermentas Inc., Hanover, MD, USA.


Isolation and characterization of phages

Figure 1 presents photographs and electron micrographs of healthy and diseased corals, bacterial pathogens and phages used in this study. The natural concentrations of phages in the seawater surrounding the corals that formed plaques on V. coralliilyticus and T. loyaeana were 5 and 1 per ml, respectively. One distinct phage for each bacterial pathogen was obtained after several rounds of plaque purification. Phage YB2 (obtained after enrichment) formed 1.5 mm clear plaques on V. coralliilyticus. It is a double stranded DNA phage containing 11 Kbp of circular DNA (Fig. 2). The uncut DNA (Fig. 2, lane 4) shows the typical three forms of circular DNA, and a single cut (Fig. 2, lane 3) yielded the single linear form. One-step growth curves of phage YB2 on V. coralliilyticus yielded a burst size of 100 in 80 min at 30°C. Phage BA3 (obtained by direct plating), which formed 2 mm clear plaques on T. loyaeana, is a double stranded DNA phage containing 15 Kbp of linear DNA (Fig. 3). One-step growth curves of phage BA3 on T. loyaeana yielded a burst size of 150 in 120 min at 30°C. Based on their structural morphologies as observed by electron microscopy, phages YB2 (Fig. 1f) and BA3 (Fig. 1h) were classified as belonging to the Corticoviridae (chloroform sensitive) and Podoviridae groups, respectively. Both phage YB2 and BA3 are highly specific for their respective hosts. Neither forms plaques on a variety of other marine bacteria tested. In addition, each phage only attacks its specific host and not other strains of the same species.
Fig. 1

Corals, bacterial pathogens and bacteriophages used in this study. a Healthy and b partially lyzed Pocillopora damicornis (bars 0.5 cm), c healthy and d partially lyzed Favia favus (bars 2 cm). Negatively stained electron micrographs of e Vibrio coralliilyticus (bar 0.2 μm), f phage YB2 (bar 50 nm), g a thin section of Thalassomonas loyaeana (bar 0.1 μm) and h phage BA3 (bar 50 nm)

Fig. 2

Agarose gel (1%) electrophoresis of bacteriophage YB2 DNA digested with restriction enzymes. Lane 1 100 bp ladder; lane 2 digestion with EcoRI; lane 3 digestion with PstI; lane 4 non-digested phage DNA; lane 5 1 Kbp ladder

Fig. 3

Agarose gel (1%) electrophoresis of bacteriophage BA3 DNA digested with restriction enzymes. Lane 1, 1 Kbp ladder; lane 2 digestion with EcoRI; lane 3 digestion with EcoRV; lane 4 digestion with HindIII; lane 5 digestion with BamHI

Adsorption of phages to bacteria

For phages to be effective in preventing bacterial infections of corals, the phage must be able to adhere to the pathogen in unsupplemented seawater. As summarized in Figs. 4 and 5, both phages YB2 and BA3 adhered to their hosts in seawater, albeit at a slower rate than in MBT medium. Approximately 60% of the input phage YB2 was bound to V. coralliilyticus in 90 min in ASW, whereas 90% was bound in 10 min in MBT medium. Adhesion of phage BA3 to T. loyaeana was only slightly slower in ASW than in MBT medium. In both cases, over 50% were bound in 10 min. When bound to their hosts in seawater, phages YB2 and BA3 did not multiply or lyse the bacteria, but when transferred to nutrient rich MBT medium, the bound phages multiplied rapidly and lysed the bacteria (data not presented).
Fig. 4

Adsorption kinetics of phage YB2 to Vibrio coralliilyticus in MBT medium (open bars) and in seawater (closed bars). Data are presented as the mean + SE

Fig. 5

Adsorption kinetics of phage BA3 to Thalassomonas loyaeana in MBT medium (open bars) and in seawater (closed bars). Data are presented as the mean + SE

Protection of P. damicornis against infection by V. coralliilyticus by phage YB2

Phage YB2 protected the coral P. damicornis against infection by V. coralliilyticus (Fig. 6). In each of the aquaria that did not receive phage, all nine corals began to lyse after 14 days and were completely devoid of tissue after 17 days. In the aquaria that contained 103 phages per ml, all corals remained healthy for at least 2 months. In a separate experiment, corals that were inoculated with V. coralliilyticus and phage YB2 and remained healthy for 33 days, were re-inoculated with the pathogen. These corals remained healthy for an additional month (Fig. 7). Since the phages were only added at the beginning of the experiment and the water was replaced weekly, it follows that sufficient phage remained associated with the coral tissue for at least 1 month to protect against the second infection. The death of the corals after 27 days (Fig. 7) was probably not the result of infection with V. coralliilyticus because the pathogen could not be isolated from these diseased corals.
Fig. 6

Protection of the coral Pocillopora damicornis against infection by Vibrio coralliilyticus with phageYB2. Coral fragments at 28°C were infected with Vibrio coralliilyticus at a final concentration of 10ml−1. Nine corals were inoculated with 103 pfu ml−1 of phage YB2 (filled triangle), and nine corals served as no phage controls (filled square). Data are presented as the mean ± SE

Fig. 7

Protection of phage-treated corals, against a second infection of Vibrio Coralliilyticus. Corals that looked healthy (for 33 days) in the Phage therapy experiment (Fig. 6) were reinfected with 105 cfu ml−1 (filled triangle). Fresh corals infected with V. coralliilyticus served as no phage controls (filled square). Data are presented as the mean ± SE. In the case of the previously treated with phage data points (filled triangle), the SE were <3%

Protection of F. favus against infection by T. loyaeana by phage BA3

The most rapid and reproducible technique for transmitting the white plague-like disease in the laboratory is to place a healthy coral in water that came from an aquarium containing a diseased coral (Fig. 8). In the absence of added phage, all the corals began to show tissue lysis in 2 days and were dead in 4 days. The corals that were treated with phage remained alive with no tissue loss for at least 21 days. The only difference between them and healthy non-infected corals was that the phage-protected corals secreted more mucus than healthy control corals for the first 3 days after infection. Both 104 and 10ml−1 phages showed the same inhibition of infection.
Fig. 8

Protection of the Favia favus against infection by Thalassomonas loyaeana with phage BA3. Nine healthy pieces of F. favus were placed in separate aquaria containing water that was taken from an aquarium that contained diseased F. favus. Six aquaria were inoculated with phage BA3 (filled triangle) and three served as no phage controls (filled square). Data are presented as the mean ± SE

During the phage therapy experiment, the concentration of phage BA3 in the aquarium water increased more than 100-fold during the first 2 h and remained high throughout the experiment (Fig. 9). After 7 days, a coral was removed from the aquarium, rinsed and then crushed in sterile seawater. The titer of phage BA3 was 7 × 106 pfu cm−2, indicating that phage remained closely associated with the coral tissue.
Fig. 9

Concentrations of phage BA3 in the aquarium water during phage therapy. Samples of water from the experiment described in Fig. 8 were titered for phage by the soft agar overlay technique. After 4, 9 and 13 days (arrows) the water was replaced with fresh seawater. Initial concentrations of phage were 104 pfu ml−1 (closed bars) and 106 pfu ml−1 (open bars). Data are presented as the mean + SE


The data presented here demonstrate in two coral model systems that inoculation of specific phages at the same time as the bacterial pathogens inhibits infection in aquaria. Since the rate of phage adsorption to its host was relatively rapid (minutes) compared to bacterial adhesion to the coral (hours), it is reasonable to assume that the phage was carried to the coral while bound to the bacterial pathogen. Once the pathogen reaches the nutritionally rich coral mucus, it begins to metabolize, allowing for phage multiplication and resulting bacterial lysis. This concept is supported by the observation that there was more than 100-fold increase in phage BA3 during the first 2 h. The titer of phage associated with coral tissue remained high for several weeks. This important finding can explain (1) how the phage titer in the water was maintained even after the water in the aquarium was replaced—by release of phage from the coral, and (2) how corals treated with phage and pathogen at day one showed increased resistance to a second bacterial infection after 33 days (Fig. 7).

Because of the high degree of host specificity, phage therapy provides an indirect but powerful tool to demonstrate that a particular microorganism is responsible for a specific disease. This is particularly relevant to the white plague-like disease, because it has not been possible to reproducibly isolate T. loyaeana from diseased corals showing signs of the disease (Barash et al. 2005). The difficulty of isolating T. loyaeana may be due to the large and diverse number of bacteria associated with corals (Rohwer et al. 2001, 2002; Koren and Rosenberg 2006), the lack of a specific medium for isolating the bacterium and/or that T. loyaeana may be in a viable-but-not-culturable (VBNC) state (Colwell et al. 1985). The data showing that the T. loyaeana-specific phage BA3 blocks the infection and that the phage multiplied on water taken from a diseased coral, demonstrate that T. loyaeana must have been present on the diseased coral and is responsible for transmitting the disease. Based on the known phage burst size, the presence of 108 pfu ml−1 2 h after infection (Fig. 9) indicates that the water taken from the aquarium that contained a diseased coral (day 0) must have had a concentration of T. loyaeana >10ml−1. Thus, together with data previously published (Barash et al. 2005), all of Koch’s postulates have now been satisfied, and it can be concluded that T. loyaeana is the causative agent of the white plague-like disease on the Eilat coral reef.

Before applying phage therapy to coral diseases in an open system, such as a coral reef, three problems have to be addressed: the most appropriate time to add the phage, possible development of phage resistance by the pathogen and obtaining enough phage for a field trial. At present, we do not know the outcome of the bacterial infections when the phages are added before or after the bacteria. This needs to be studied. If phage resistance becomes a problem, it may be necessary to use a “cocktail” of phages (O’Flynn et al. 2004). The frequency of mutation of two or more phages is extremely low. Regarding the number of phages needed for a field trial, let us assume that 103 phages ml−1 will prevent the spread of the disease. (This value is 1,000 times higher than their natural abundance in Eilat seawater). A titer of 1011 phages per ml can be reached in a fermentor. Thus, a 100-l laboratory fermentor will provide 1016 phages, enough to treat 10m2 of a coral reef to a depth of 10 m. A commercial fermentor (e.g., 100 m3) would probably have to be used to prepare enough phage for treating large reef areas (e.g., 1,000 km2). Phage therapy of coral diseases appears to be achievable.



We thank L. Doron for helpful suggestions, R.J. Martinez, G. Cohen and D. Harvell for critical reading of the manuscript and Gil Sharon for assistance in collecting corals. This research was supported by grants from the Israel Center for the Study of Emerging Diseases, the Israel Science Foundation and the World Bank Coral Disease and bleaching Groups.


  1. Adams MH (1959) Bacteriophage. Interscience Publishers, New YorkGoogle Scholar
  2. Barash Y, Sulam R, Loya Y, Rosenberg E (2005) Bacterial Strain BA-3 and a filterable factor cause a white plague-like disease in corals from the Eilat coral reef. Aquat Microb Ecol 40:183–189Google Scholar
  3. Ben-Haim Y, Rosenberg E (2002) A novel Vibrio sp. pathogen of coral Pocillopora damicornis. Mar Biol 141:47–55CrossRefGoogle Scholar
  4. Ben-Haim Y, Zicherman-Keren M, Rosenberg E (2003a) Temperature-regulated bleaching and lysis of the coral Pocillopora damicornis by the novel pathogen Vibrio coralliilyticus. Appl Environ Microbiol 69:4236–4242CrossRefGoogle Scholar
  5. Ben-Haim Y, Thompson FL, Thompson CC, Cnockaert MC, Hoste B, Swings J, Rosenberg E (2003b) Vibrio coralliilyticus sp. nov., a temperature-dependent pathogen of the coral Pocillopora damicornis. Int J Syst Evol Microbiol 53:309–315CrossRefGoogle Scholar
  6. Bourne DG, Munn CB (2005) Diversity of bacteria associated with the coral Pocillopora damicornis from the Great Barrier Reef. Environ Microbiol 7:1162–1174CrossRefGoogle Scholar
  7. Bruno JF, Petes LE, Harvel CD, Hettinger A (2003) Nutrient enrichment can increase the severity of coral diseases. Ecol Lett 6:1056–1061CrossRefGoogle Scholar
  8. Chanishvili N, Chanishvili T, Tediashvili M, Barrow PA (2001) Phages and their application against drug-resistant bacteria. J Chem Technol Biotechnol 76:689–699CrossRefGoogle Scholar
  9. Colwell RR, Brayton PR, Grimes DJ, Roszak DB, Huq SA, Palmer LM (1985) Viable but non-culturable Vibrio cholerae and related pathogens in the environment: implications for release of genetically engineered microorganisms. Biotechnology 3:817–820CrossRefGoogle Scholar
  10. Green E, Bruckner A (2000) The significance of coral disease epizootiology for coral reef conservation. Biol Conserv 96:347–361CrossRefGoogle Scholar
  11. Harvell CD, Mitchell CE, Ward JR, Altizer S, Dobson AP, Ostfeld RS, Samuel MD (2002) Climate warming and disease risks for terrestrial and marine biota. Science 296:2158–2162CrossRefGoogle Scholar
  12. Kerri M, Mullen EC, Peters C, Harvell D (2004) Coral resistance to disease. In: Rosenberg E, Loya Y (eds) Coral health and disease. Springer, Berlin Heidelberg New York, pp 377–399Google Scholar
  13. Kline DI, Kuntz NM, Breitbart M, Knowlton N, Rohwer F (2006). Role of elevated organic carbon and microbial activity in coral mortality. Mar Ecol Prog Ser 314:119–125Google Scholar
  14. Koren O, Rosenberg E (2006) Bacteria associated with mucus and tissues of the coral Oculina patagonica in the summer and winter. Appl Environ Microbiol AEM00554–06 (in press)Google Scholar
  15. Kuntz NM, Kline DI, Sandin SA, Rohwer F (2005) Pathologies and mortality rates caused by organic carbon and nutrient stressors in three Caribbean coral species. Mar Ecol Prog Ser 294:173–180Google Scholar
  16. Kushmaro A, Loya Y, Fine M, Rosenberg E (1996) Bacterial infection and coral bleaching. Nature 380:396CrossRefGoogle Scholar
  17. Lederberg J (1996) Smaller fleas ad infinitum: therapeutic bacteriophage redux. Proc Natl Acad Sci USA 93:3167–3168CrossRefGoogle Scholar
  18. Nair SV, Del Valle H, Gross PS, Terwilliger DP, Smith LC (2005) Macroarray analysis of coelomocyte gene expression in response to LPS in the sea urchin. Identification of unexpected immune diversity in an invertebrate. Physiol Genomics 22:33–47CrossRefGoogle Scholar
  19. Nakai T, Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153:13–18CrossRefGoogle Scholar
  20. O’Flynn G, Ross RP, Fitzgerald GF, Coffey A (2004) Evaluation of a Cocktail of three Bacteriophages for Biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol 70:3417–3424CrossRefGoogle Scholar
  21. Richardson LL (1998) Coral diseases: what is really known? Trends Ecol Evol 13:438–443CrossRefGoogle Scholar
  22. Ritchie KB, Polson SW, Smith GW (2001) Microbial disease causation in marine invertebrates: problems, practices, and future prospects. Hydrobiologia 460:131–139CrossRefGoogle Scholar
  23. Rohwer F, Breitbart M, Jara J, Azam F, Knowlton K (2001) Diversity of bacteria associated with the Caribbean coral Monastrea franksi. Coral Reefs 20:85–91CrossRefGoogle Scholar
  24. Rohwer F, Seguritan V, Azam F, Knowlton K (2002) Diversity and distribution of coral-associated bacteria. Mar Ecol Prog Ser 243:1–10Google Scholar
  25. Rosenberg E, Ben-Haim Y (2002) Microbial diseases of corals and global warming. Environ Microbiol 4:318–326CrossRefGoogle Scholar
  26. Sambrook JE, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press, New YorkGoogle Scholar
  27. Sulakvelidze A, Alavidze Z, Morris Jr JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649–659CrossRefGoogle Scholar
  28. Thompson FL, Barash Y, Sawabe T, Sharon G, Swings J, Rosenberg E (2006) Thalassomonas loyana sp. nov., a causative agent of the white plague-like disease of corals on the Eilat coral reef. Int J Sys Evol Microbiol 56:365–368CrossRefGoogle Scholar
  29. Weld RJ, Butts C, Heinemann JA (2004) Models of phage growth and their applicability to phage therapy. J Theor Biol 227:1–11CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • R. Efrony
    • 1
  • Y. Loya
    • 2
  • E. Bacharach
    • 3
  • E. Rosenberg
    • 1
    Email author
  1. 1.Department of Molecular Microbiology and BiotechnologyTel Aviv UniversityRamat AvivIsrael
  2. 2.Department of ZoologyTel Aviv UniversityRamat AvivIsrael
  3. 3.Cell Research and ImmunologyTel Aviv UniversityRamat AvivIsrael

Personalised recommendations